Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

BACKGROUND & AIMS Nonalcoholic steatohepatitis (NASH) is a disorder that consists of steatosis and hepatic inflammation. It is not known why only some people with steatosis develop NASH. Recently, we identified dietary cholesterol as a factor that directly leads to hepatic inflammation and hepatic foam cell formation. We propose a mechanism by which Kupffer cells (KCs) take up modified cholesterol-rich lipoproteins via scavenger receptors (SRs). KCs thereby accumulate cholesterol, become activated, and may then trigger an inflammatory reaction. Scavenging of modified lipoproteins mainly depends on CD36 and macrophage scavenger receptor 1. METHODS To evaluate the involvement of SR-mediated uptake of modified lipoproteins by KCs in the development of diet-induced NASH, female low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice were lethally irradiated and transplanted with bone marrow from Msr1(+/+)/Cd36(+/+)or Msr1(-/-)/Cd36(-/-) mice and fed a Western diet. RESULTS Macrophage and neutrophil infiltration revealed that hepatic inflammation was substantially reduced by approximately 30% in Msr1(-/-)/Cd36(-/-)-transplanted mice compared with control mice. Consistent with this, the expression levels of well-known inflammatory mediators were reduced. Apoptotis and fibrosis were less pronounced in Msr1(-/-)/Cd36(-/-)-transplanted mice, in addition to the protective phenotype of natural antibodies against oxidized low-density lipoprotein in the plasma. Surprisingly, the effect on hepatic inflammation was independent of foam cell formation. CONCLUSIONS Targeted inactivation of SR pathways reduces the hepatic inflammation and tissue destruction associated with NASH, independent of hepatic foam cell formation.

[1]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[2]  F. Bäckhed,et al.  Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. , 2009, The Journal of clinical investigation.

[3]  K. Moore,et al.  Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[4]  N. Maeda,et al.  Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis , 2008, Hepatology.

[5]  M. Febbraio,et al.  Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II. , 2008, Cardiovascular research.

[6]  M. Honda,et al.  Lipid‐induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet , 2007, Hepatology.

[7]  C. Schumann,et al.  Lipopolysaccharides from atherosclerosis‐associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2‐induced inflammatory responses in human vascular endothelial cells , 2007, Cellular microbiology.

[8]  F. Anania,et al.  Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. , 2007, Gastroenterology.

[9]  E. Brilakis,et al.  Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events Published, JLR Papers in Press, November 8, 2006. , 2007, Journal of Lipid Research.

[10]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[11]  A. Colell,et al.  Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. , 2006, Cell metabolism.

[12]  Mason W Freeman,et al.  Scavenger receptors in atherosclerosis: beyond lipid uptake. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[13]  N. Maeda,et al.  Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates. , 2006, Journal of hepatology.

[14]  S. Hazen,et al.  A CD36‐dependent signaling cascade is necessary for macrophage foam cell formation , 2006, Cell metabolism.

[15]  A. von Eckardstein,et al.  Brain Cholesterol Synthesis in Mice Is Affected by High Dose of Simvastatin but Not of Pravastatin , 2006, Journal of Pharmacology and Experimental Therapeutics.

[16]  K. Moore,et al.  Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.

[17]  K. Moore,et al.  Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain , 2005, The Journal of cell biology.

[18]  M. Vidali,et al.  Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis , 2005, Gut.

[19]  A. Kahraman,et al.  Apoptosis and fibrosis in non-alcoholic fatty liver disease. , 2005, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[20]  Thomas Hartung,et al.  CD36 is a sensor of diacylglycerides , 2005, Nature.

[21]  D. Malide,et al.  Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2005, Journal of Biological Chemistry.

[22]  L. J. van der Laan,et al.  Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process , 2004, International journal of experimental pathology.

[23]  S. Gordon,et al.  The Class A Macrophage Scavenger Receptor Attenuates CXC Chemokine Production and the Early Infiltration of Neutrophils in Sterile Peritonitis1 , 2004, The Journal of Immunology.

[24]  D. Broide,et al.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. , 2004, The Journal of clinical investigation.

[25]  A. McCullough,et al.  The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[26]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[27]  K. Fassbender,et al.  High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs , 2004, Steroids.

[28]  K. Reue,et al.  Cholesterol and Cholate Components of an Atherogenic Diet Induce Distinct Stages of Hepatic Inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[29]  M. Päivänsalo,et al.  Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis , 2003, Circulation.

[30]  S. Baksh,et al.  Apoptotic Cells Induce Migration of Phagocytes via Caspase-3-Mediated Release of a Lipid Attraction Signal , 2003, Cell.

[31]  P. Ruvolo.  Intracellular signal transduction pathways activated by ceramide and its metabolites. , 2003, Pharmacological research.

[32]  K. Moore,et al.  Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.

[33]  H. Kruth,et al.  Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2002, The Journal of Biological Chemistry.

[34]  H. Jaeschke.  Neutrophil-mediated tissue injury in alcoholic hepatitis. , 2002, Alcohol.

[35]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[36]  Robert Kleemann,et al.  Negative Regulation of Human Fibrinogen Gene Expression by Peroxisome Proliferator-activated Receptor α Agonists via Inhibition of CCAAT Box/Enhancer-binding Protein β* , 2001, The Journal of Biological Chemistry.

[37]  G. Bondjers,et al.  Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A2 , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[38]  B. Aggarwal,et al.  TNF-Induced Signaling in Apoptosis , 1999, Journal of Clinical Immunology.

[39]  S. Hazen,et al.  Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. , 1999, The Journal of clinical investigation.

[40]  H. Jaeschke,et al.  Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and fas‐antibody–induced liver injury , 1998, Hepatology.

[41]  Yukiko Kurihara,et al.  A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.

[42]  J. Maher,et al.  Adenovirus‐mediated expression of cytokine‐induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis , 1997, Hepatology.

[43]  S Gordon,et al.  Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  T. Kodama,et al.  Tissue distribution, intracellular localization, and in vitro expression of bovine macrophage scavenger receptors. , 1991, The American journal of pathology.

[45]  ESBRA 2007. Abstracts of the 11th Congress of the European Society for Biomedical Research on Alcoholism, 23-26 September, Berlin, Germany. , 2007, Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.

[46]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[47]  佐野 純一.  Foam cells generated by a combination of hyperglycemia and hyperlipemia in rats , 2004 .

[48]  R. Silverstein,et al.  CD 36 : a class B scavenger receptor involved in angiogenesis , atherosclerosis , inflammation , and lipid metabolism , 2001 .

[49]  B Staels,et al.  Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. , 2001, The Journal of biological chemistry.

[50]  E. Dennis,et al.  Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.